Combinations for the treatment of diseases involving cell proliferation, migration or apoptosis of myeloma cells, or angiogenesis

Details for Australian Patent Application No. 2004233576 (hide)

Owner Boehringer Ingelheim International GmbH

Inventors Hilberg, Frank; Van Meel, Jacobus C.A.; Baum, Anke; Solca, Flavio; Munzert, Gerd; Stefanic, Martin Friedrich

Agent Davies Collison Cave

Pub. Number AU-B-2004233576

PCT Pub. Number WO2004/096224

Priority 04001171.0 21.01.04 EP; 03009587.1 29.04.03 EP; 04000508.4 13.01.04 EP

Filing date 24 April 2004

Wipo publication date 11 November 2004

Acceptance publication date 29 July 2010

International Classifications

A61K 31/496 (2006.01) - Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene

A61K 31/517 (2006.01) - ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine

A61K 31/56 (2006.01) - Compounds containing cyclopenta[a]hydrophenanthrene ring systems

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

8 December 2005 PCT application entered the National Phase

  PCT publication WO2004/096224 Priority application(s): WO2004/096224

29 July 2010 Application Accepted

  Published as AU-B-2004233576

25 November 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004233577-Diazabicyclononene derivatives

2004233575-9-azabicyclo'3.3.1!non-6-ee derivatives with a heteroatom at the 3-position as renin inhibitors